Duloxetine Hcl Capsule, Delayed Release
Product Images NDC 80425-0012

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine Hcl (NDC 80425-0012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Duloxetine HCl Dr 30m Cap #30 (Duloxetine HCl Dr 30mg Cap Qty 30 Ndc80425 0012)

Duloxetine HCl Dr 30m Cap #30 (Duloxetine HCl Dr 30mg Cap Qty 30 Ndc80425 0012)
FDA Label Image

Duloxetine HCl Dr 30m Cap #60 (Duloxetine HCl Dr 30mg Cap Qty 60 Ndc 80425 0012)

Duloxetine HCl Dr 30m Cap #60 (Duloxetine HCl Dr 30mg Cap Qty 60 Ndc 80425 0012)
The text seems to be a product label or prescription label for Duloxetine HCL 60mg capsules. It includes the name of the manufacturer "Advanced" and some identifying numbers. It is not clear what "Compare 120" refers to. The rest of the text is not available or is unreadable due to errors.*
FDA Label Image

Structure (Image 0)

Structure (Image 0)
FDA Label Image

Figure_1 (Image 1)

Figure_1 (Image 1)
This appears to be a graph displaying the proportion of patients who experienced a relapse over time from randomization. The graph compares the treatment groups of a placebo and duloxetine. The horizontal axis represents the time in days, while the vertical axis represents the proportion of patients with relapse.*
FDA Label Image

Figure_2 (Image 2)

Figure_2 (Image 2)
FDA Label Image

Figure_3 (Image 3)

Figure_3 (Image 3)
FDA Label Image

Figure_4 (Image 4)

Figure_4 (Image 4)
FDA Label Image

Figure_5 (Image 5)

Figure_5 (Image 5)
FDA Label Image

Figure_6 (Image 6)

Figure_6 (Image 6)
FDA Label Image

Figure_8 (Image 7)

Figure_8 (Image 7)
This appears to be a chart showing the percentage of patients who experienced improvement in pain levels after taking a placebo or a medication called "Didoreine" at a dosage of 601120 g once a day. The chart displays the percentage of improvement from baseline pain levels, with values ranging from 0 to 100. However, the result is not readable in some parts, making it difficult to provide a complete and accurate description.*
FDA Label Image

Figure_9 (Image 8)

Figure_9 (Image 8)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.